Source: Journal of Leukocyte Biology. Unidades: IQ, ICB
Subjects: IMUNOLOGIA, FÁRMACOS IMUNOSSUPRESSORES, BIOTA INTESTINAL, CÉLULAS DENDRÍTICAS, COLITE ULCERATIVA, CÉLULAS MIELOIDES, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, CITOESQUELETO, CITOCINAS, INTERLEUCINA 6
ABNT
IGNACIO, Aline et al. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis. Journal of Leukocyte Biology, v. 116, n. 4, p. 779-792, 2024Tradução . . Disponível em: https://doi.org/10.1093/jleuko/qiae084. Acesso em: 24 abr. 2026.APA
Ignacio, A., Cipelli, M., Takiishi, T., Aguiar, C. F., Terra, F. F., Ghirotto, B., et al. (2024). Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis. Journal of Leukocyte Biology, 116( 4), 779-792. doi:10.1093/jleuko/qiae084NLM
Ignacio A, Cipelli M, Takiishi T, Aguiar CF, Terra FF, Ghirotto B, Silva EM da, Castoldi A, Magalhães YT, Antonio T, Padovani BN, Hiyane MI, Andrade-Oliveira V, Forti FL, Camara NOS. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis [Internet]. Journal of Leukocyte Biology. 2024 ; 116( 4): 779-792.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1093/jleuko/qiae084Vancouver
Ignacio A, Cipelli M, Takiishi T, Aguiar CF, Terra FF, Ghirotto B, Silva EM da, Castoldi A, Magalhães YT, Antonio T, Padovani BN, Hiyane MI, Andrade-Oliveira V, Forti FL, Camara NOS. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis [Internet]. Journal of Leukocyte Biology. 2024 ; 116( 4): 779-792.[citado 2026 abr. 24 ] Available from: https://doi.org/10.1093/jleuko/qiae084
